Drug Shortage Report for MILRINONE LACTATE INJECTION, USP

Last updated on 2017-04-08 History
Report ID 2996
Drug Identification Number 02244622
Brand name MILRINONE LACTATE INJECTION
Common or Proper name Milrinone Lactate Injection 1 mg/mL SD Vial 20 mL
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) MILRINONE
Strength(s) 1.0MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 20mL
ATC code C01CE
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-03-20
Actual start date
Estimated end date
Actual end date 2017-04-07
Shortage status Resolved
Updated date 2017-04-08
Company comments Available at all locations Friday April 7th.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2017-04-08 English Compare
v7 2017-04-05 French Compare
v6 2017-04-05 English Compare
v5 2017-04-05 English Compare
v4 2017-03-21 English Compare
v3 2017-03-15 French Compare
v2 2017-03-15 English Compare
v1 2017-03-15 English Compare

Showing 1 to 8 of 8